Related Experiment Video
Updated: Aug 10, 2025
08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
6.1K
The urgent need for innovation in contraception
Daniel S Johnston1,2,3, Gregory S Kopf4,5
1Contraception Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Biology of Reproduction
|February 13, 2023
Summary
New contraceptive development is crucial due to unmet global needs. Advancements in biomedical science and technology can accelerate the creation of innovative male and female contraceptive methods, enhancing reproductive autonomy.
Area of Science:
- Biomedical Science
- Biomedical Engineering
- Drug Development Technologies
Background:
- Significant unmet global need for novel male and female contraceptive methods persists despite medical progress.
- Existing contraceptive options have limitations, necessitating the development of improved alternatives.
Purpose of the Study:
- To highlight the critical need for innovative contraceptive methods for both men and women.
- To explore opportunities presented by advancements in biomedical science and related technologies for contraceptive development.
- To emphasize the importance of industry involvement in bringing new contraceptive options to market.
Main Methods:
- Review of current unmet needs in contraception.
- Analysis of opportunities arising from biomedical science advancements.
- Discussion of strategies for developing novel contraceptive methods.
- Evaluation of the role of drug development accelerators and industry partnerships.
Main Results:
- Identified a substantial global demand for new and enhanced contraceptive solutions.
- Highlighted the potential of interdisciplinary advancements to drive innovation in reproductive health.
- Outlined strategic approaches to accelerate the development and implementation of novel contraceptives.
Conclusions:
- Advancements in biomedical science, engineering, and drug development are key to creating innovative contraceptives.
- Industry collaboration and the use of development accelerators are vital for expanding reproductive autonomy globally.
Related Concept Videos
01:22Birth Control Methods
515
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
515
01:24In Vitro Fertilization
349
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
349
01:28Infertility in Females
368
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
368
01:38Fertilization
71.3K
During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...
71.3K
01:30Hormonal Control of the Ovarian Cycle
774
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
774
01:27Ovarian Cycle
1.5K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.5K